The results from the Kaplan–Meier analysis suggested that increased ALKBH7 expression was associated with a poor prognosis for patients with PRAD, while decreased ALKBH7 expression was associated with a poor prognosis for patients with THCA (Supplementary Figure S1). This evidence concerns the gene ALKBH7 and prostate adenocarcinoma.